This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.

Name: This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.
Published: 2022
License: Public Domain

The First Affiliated Hospital of Soochow University · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

relapsed and/or refractory multiple myeloma, interventional, early_phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.

Related documents